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The role of the Pulmonary Function Laboratory
has been expanded in recent years by the commercial
development and marketing of equipment capable of
measuring accurately and easily static lung volumes,
diffusing capacity, and arterial blood gases. These
sophisticated measurements, which were once the
purview of research physiologists, are now readily
attainable as screening measurements in most comm unity hospitals. This review is intended not as a
summary of the entire field or as a technical guide for
performance of pulmonary function tests but as a
survey of some clinical applications and pitfalls of
screening tests and a statement of guidelines for their
use. It is assumed that the reader already has some
experience in ordering and interpreting routine spirograms and arterial blood gases.
Pulmonary function tests are intended to answer
four questions:
1) Is the patient restricted?
2) Is the patient obstructed?
3) Does the patient have abnormalities of gas
exchange?
4) Are the observed abnormalities compatible
with the patient's symptoms and clinical diagnosis?
Restriction is a reduction of total lung capacity
or one of its subvolumes (Fig I) as a result of collapse
or volume displacement of the lung (fibrothorax), increased elastic recoil of the lungs (pulmonary fibrosis), increased elastic recoil of the rib cage or abdomen (obesity), or loss of forces needed to overcome
normal elastic recoil (muscular dystrophy) . It is im-
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portant to realize that a routine spirometric vital
capacity measurement may not adequately describe
the presence or degree of restriction. For example,
some patients with advanced emphysema may have
reduced vital capacity in the face of a large residual
volume, with increased total lung capacity caused by
obstructive air trapping; it is misleading to label such
patients as "restricted" on the basis of reduced vital
capacity when, in fact, they are overinflated. On the
other hand, true early restriction may occur in the
face of normal vital capacity. An example of this is
obesity, a condition in which the abdominal mass
renders the chest wall less compliant by hindering
downward displacement of the diaphragm. The
earliest change in the restrictive pattern of obesity is a
marked reduction in expiratory reserve volume
(ERV) (see Fig I) but only minor alterat.ions of the
total lung and vital capacities. Therefore, accurate
evaluation of patients with suspected restrictive disorders should include, in addition to routine spirometry, a measurement of total lung capacity and its
subdivisions by inert gas or plethysmographic techniques. The following case illustrates the use of pulmonary function studies in following the course of a
restrictive lung disorder:
Case I. A 53-year-old white woman developed exertional
dyspnea and cough in 1971. A chest roentgenogram revealed bilateral basilar "ground-glass" opacities. In April
1972, an open lung biopsy showed desquamative interstitial
pneumonia. She was placed on 20 mg prednisone daily in
August 1972, and sequential pulmonary function tests were
performed (Table I). The initial vital and total lung capacities were consistent with moderately severe restriction, and
there was a correspondingly severe reduction in diffusing
capacity. After two years of prednisone therapy, these abnormalities improved substantially (October 1974). When
steroids were stopped she experienced a severe relapse
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(February 1976) which was reversed by their resumption
(February 1977) . In 1977 she was in remission while taking
20 mg prednisone on alternate days·. The pulmonary June·
tion studies provided quantitative objective evidence that a
prolonged course of steroid therapy was necessary.

Obstructive impairment, defined as a reduction
in inspiratory or expiratory air-flow rates, is a result
of intrinsic airway disease or loss of lung elastic recoil. The latter causes airways to lose their structural
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Fig 1-Spirogram with various subdivisions of total lung capacity.
Initial deflections at left are tidal volumes recorded on slowly
moving recording paper. Large deflection upward is inspiration to
total lung capacity, followed by expiration to residual volume and
resumption of tidal breathing. Residual volume is not measured
directly, but has been previously determined by inert gas study.
Time is on the horizontal axis, volume on the vertical.

support. Intrinsic airway disease may be caused by a
variety of conditions ranging from totally reversible
asthmatic bronchoconstriction to irreversible advanced chronic bronchitis with bronchiolitis obliterans. Loss of elastic recoil almost always is a result of
localized or generalized emphysema.
Because the conditions causing airways obstruction tend to become more exaggerated during forced
expiration (during which alveoli and airways are rapidly diminishing in both length and diameter), the
conventional method of assessing obstructive impairment is by measuring averaged flow rates on a volume-time curve of an ordinary spirogram during a
maximally forced expiration of the vital capacity.
(Fig 2). Although one could arbitrarily measure flow
at a multitude of points on the curve, three measurements have been standardized and used most frequently (see Fig 2): the timed vital capacity (FEY 1 );
the ratio of FEY, to total vital capacity; and the
maximum mid-expiratory flow rate (MMEF) (the averaged flow over the mid-half of the vital capacity).
Ordinarily all three measurements are made and abnormalities of one tend to correlate with those of the
others. Additional measurements such as peak flow,
total expiratory time, and forced expiratory volume
in three seconds, or "FEY3 , " add little new information but may be sensitive indicators of changes when
evaluating drug effects in population samples.
Obstruction is conventionally quantitated during expiration; however, patients develop dyspnea
from obstructive impairment because of the increased
work of breathing during inspiration. In most cases,
obstruction during inspiration is inferred by abnormalities in the FEY, and MMEF; unfortunately,
there are several important exceptions to this. Individuals with obstruction isolated to the trachea or
larynx (for example, tracheomalacia following endotracheal intubation) may not have evidence of exTABLE I
Sequential Function Studies in a Patient with Desquamative
Interstitial Pneumonia.
August October February February Pre·
1972
1974
1976
1977 dieted
Vital capacity,
liters
2.06
Total lung
capacity,
liters
3.55
Arterial Po,,
torr
66
Diffusing capacity,
ml/ min/ torr
8.5

3.45

2.30

3.12

3.97

5.24

3.79

4.95

6.32

73

67

76

90

17.0

7.9

11 .2

22.0
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Fig 2-Forced vit al capacity show n on rapidly movlng recording
paper. Total downward excursion of curve (vertical axis) is vital
capacity. Volume exhaled during th e first second is FEY,. MMEF
is slope of line co nnecting points A and B. Time is on the horizonta l axis.

piratory obstruction if their defect is a bove the thoracic outlet, or the y m ay h ave spirometric
abno rmalities which are misinterpreted as generalized airways obstruction if their defect is below the
thoracic outlet. In addition, individuals with substa nti al narrow ing of bronchioles but no rmal patency
of bronchi (for exa mpl e, young s mokers with early
chronic bronchitis) may have completely normal
spiro metric flow rates but isolated a bnormalities of
MM EF which are difficult to interpret because of the
large sta ndard deviation of this test in the normal
population.
When either of these exceptions is suspected ,
additiona l information may be obtained by a recording of a flow-v ol ume curve, or graphical representation of instantaneous mouth flow and expired volume
during a forced inspiration and expiration of the vital
capacity (Fig 3 ). The norm al configuration of this
curve is shown in Figure 3a. Fixed obstruction in the
trachea produces a characteristic fixed limitation to
flow which is independent of volume (Fig 3b ). An
addition al advantage of the flow-volume curve is its
depiction of inspiratory events, thus faci litating the
detection of variable extrathoracic upper-airw ay obstruction (Fig 3c ). Generalized bronchiol a r narrowing produces flow limitations which are detecta bl e
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Fig 3a- l nspiratory-expiratory flow-volume curve shows normal
co nfi gurat ion in a 28-year-old man .
Fig 3b-Fi xed upper-airway obstruction seen in a 32-year-old man
with stenosis of intrat horacic trachea.
Fig Jc- Curve shows variable extrathoracic obstructi on as a result
of loss of carti lagenous tracheal support in the subg lottic region.
The weakened area collapses on inspiration but is distended during
expiration by positive airway pressure.
Fig 3d- " I nwardly concave" distortion of the exp ired cu rve at
lower lu ng vo lum es is seen in a 30-year-old chronic cigarette
smoker wit h a norma l spirograni. The distortion is due to
bronchiolar obstructio n.

only on expiration at lower lung volumes a nd tend to
worsen as volume diminishes. Thi s will result in an
"inwardly concave" ap pearance to the flow-volume
curve in patients with obstruction limited to the bronchioles (Fig 3d). It should be pointed out that this
"inwardly concave" configuration is not specific for
periphera l sma ll airways obstruction; if the spirogram also indicates obstruction, the curve is not use-
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fut for differentiating generalized obstruction from
that isolated to peripheral airways. The following
case is an example of obstructive impairment and
also illustrates the value of lung volume determinations by the helium dilutional method in differentiating obstructive from restrictive impairment:
Case 2. A 19-year-old male gas station attendant abruptly
developed exertional dyspnea in January 1976. Seven
months later a carefully taken history revealed that he had
been caring for his brother's homing pigeons since late
December 1975. The ·chest roentgenogram was normal ,
although symptoms persisted. Pulmonary function studies
(Table 2, July 1976) revealed a reduced vital capacity;
however, the total lung capacity and residual volume suggested probable obstructive air trapping rather than restriction. The FEV 1 and MMEF confirmed obstruction. With-

out specific treatment other than ceasing the pigeon
exposure, his symptoms resolved and objective improvement
was evident on sequential studies (September 1976). Although both restriction and obstruction may occur in a llergic alveolitis, restriction is usually the dominant impairment. However, in this patient 's case, obstruction occurred
without restriction.

Arterial hypoxemia is a sequela of impaired gas
exchange; however, measurement of resting arterial
oxygen tension (Po 2) alone may not be sufficiently
sensitive to detect such impairment. Impaired gas
exchange is also present if there is an increase in the
observed oxygen tension difference between alveolar
air and arterial blood (DA-a 0 2) or if there is an
abnormality in the diffusing capacity for carbon
monoxide. For ambulatory patients breathing room
air, DA-a 0 2 can be estimated by obtaining a sample
of arterial blood under steady-state conditions. Alveolar oxygen tension is calculated by the standard
alveolar air equation:
PA02

0°

= F102(713) = Paco2 (F 10 2 + 1 - ; 2)

F 102 = fraction of02 in inspired air
arterial Pco 2 (identical to mean alveolar
Pco2)

Paco 2
RQ

=

respiratory quotient

The achievement of steady-state conditions is an essential prerequisite for this test because the estimation of alveolar oxygen tension is based on the assumption that the ratio of C0 2 produced to 0 2
consumed (RQ) is 0.8. Transient hyperventilation
caused by anxiety or pain will invalidate this assumption. Direct measurement of RQ may provide a more

TABLE 2
Sequential Function Studies in a Patient with Allergic Alveolitis Due to Pigeon Exposure.

Vital capacity,
liters
Total lung
capacity, liters
Residual volume,
liters
FEY 1 , liters
FEV 1 / Vital
Capacity,%
MMEF, liters/ sec.

July
1976

September
1976

Predicted

3.98

4.42

5.62

6.95

6.68

7.34

2.97
2.51

2.26
3.09

1.72
4.54

63
1.24

70
2.03

80
4.90

refined estimation of PA 0 2; however, this also requires sampling under steady-state conditions. For
either approach, hyperventilation may be avoided by
inserting an arterial cannula and allowing the patient
to rest prior to sample collection.
The measurement of carbon monoxide diffusing
capacity by the simplified single-breath technique requires the patient to breath hold at total lung capacity
for ten seconds. Patients who are markedly dyspneic
at rest may not be able to perform this test. Despite
these limitations, useful results are forthcoming for
most cooperative subjects.
The precise pathophysiologic explanation for
impaired diffusion of carbon monoxide in lung diseases is unknown. Most authorities agree that it is a
sign of alveolar or capillary destruction. Therefore,
impaired CO uptake may occur in parenchymal destructive processes such as idiopathic fibrosing alveolitis, scleroderma, advanced sarcoidosis, and in
vascular obliterative processes such as idiopathic pulmonary hypertension or multiple small pulmonary
emboli. It is also impaired in processes causing reversible loss of functioning alveoli, examples of which
are bacterial pneumonia and alveolar proteinosis. CO
uptake is impaired in generalized emphysema due to
emphysematous destruction of alveoli but remains.
nearly normal in chronic bronchitis because the destructive process is confined to airways and centrilobular elements of the parenchyma. Diffusing capacity may be spuriously impaired by several conditions.
The first is the presence of severe anemia, which
limits the availability of hemoglobin CO receptors;
the second is that failure to achieve true total lung
capacity during the breathhold will reduce CO uptake in proportion to the reduction in potential lung
volume. The following case illustrates the value of the
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0 2 were also normal. However, a moderately severe reduction in diffusing capacity suggested the presence of widespread interstitial disease despite the clear roentgenographic
lung fields. Hemoglobin was normal. A transbronchoscopic
lung biopsy showed interstitial non-caseating granulomata
consistent with sarcoidosis.

TABLE 3
Pulmonary Function Studies in a Patient with Sarcoidosis
Vital capacity, liters
FEY" liters
FEY/vital
capacity,%
MMEF,
liters/second
Total lung capacity,
liters
Residual volume,
liters
Pao,, torr
DA-a 0 2 , torr
Diffusing capacity,
ml/ min/ torr

September 1978
2.98
2.68

Predicted
3.63
2.88

90

79

4.03

3.37

3.85

5.12

.76
92
13

1.49
90
15

12.0

21.7

diffusing capacity in screening patients for the presence of gas exchange impairment:
Cas~ 3. A 32-year-old woman complained of mild exertional dyspnea of two months duration. Chest roentgenogram q:vealed bilateral hilar adenopathy. Pulmonary function studies (Table 3) showed a modest reduction in total
lung capacity (75% predicted) with normal vital capacity
anq flow rates. Resting arterial oxygen tension and DA-a

Although measured impairment in pulmonary
function frequently provides an objective explanation
for the presence of dyspnea, many patients may experience this symptom because of abnormalities which
are undetectable on screening evaluations. Negative
screening studies should stimulate a careful search for
vascular disease or nonpulmonary causes of dyspnea.
For example, "metabolically justified" hyperpnea
and dyspnea may accompany hyperthyroidism; patients with mitral stenosis or early congestive heart
failure may have only mild impairment in lung mechanics despite severe exertional dyspnea; and patients with partial obliteration of the pulmonary vasculature may have normal lung mechanics, arterial
oxygen tensions, and diffusing capacities while at
rest, only to show abnormalities during exercise.
For a variety of vascular and interstitial pulmonary disorders, it may be appropriate to evaluate

TABLE 4
Guidelines for Ordering Medical or Surgical Screening Pulmonary Function Studies.
I. Asymptomatic non-smoker

No studies; "routine spirogram" (vital capacity, FEY" MMEF) if thoracic
surgery is planned.

2. Asymptomatic smoker

Routine spirogram; add resting arterial blood gases if t horacic surgery is
planned.

3. Heavy smoker with dyspnea and/ or chronic bronchitis

Routine spirogram; total lung capacity; diffusing capacity; resting arterial
blood gases.

4. Young asthmatic

Spirogram before and after an inha led bronchodilator.

5. "Old" asthmatic (> 30 years)

Spirogram before and after inhaled bronchodilator; tota l lung capacity: resting
arterial blood gases.

6. Suspected tracheal obstruction, stridor, or unexplained obstruction on a previous spirogram

lnspiratory and expiratory flow- volume curve.

7. Suspected interstitial lung disease

Spirogram; total lung capacity; diffusing capacity; steady-state arteria l blood
gases with DA-a 0 2 •

8. Suspected pulmonary vascular disease

Same as #7. Add exercise DA-a 0 2 , physiologic deadspace, end tidal CO,
gradient.

9. Suspected a natomic right-to-left shunt

Arteria l blood gases whi le breathing I00% 0 2 • This st udy should never be
requested for patients with emphysema or chronic bronchitis who have CO,
retention .

I0. Suspected early small-airways disease

In view of the limited clinical benefits, adequate evaluation is too expensi ve.
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physiology during exercise as resting abnormalities
frequently are exaggerated during exercise. However,
pulmonary exercise testing, unlike cardiac stress testing, should provide a graded low level of exercise
(doubling or tripling of the oxygen uptake) rather
than maximum stress. In fact, recent experimental
evidence' has suggested that maximum stress measurements are potentially misleading because normal
subjects may demonstrate transient abnormalities in
Pao 2 and DA-a 0 2 while performing temporary but
severe tasks such as rapid stair-climbing. Although a
complete discussion of exercise physiology testing is
beyond the scope of this paper, som'e recent reviews
of the relevance of pulmonary exercise testing in clinical medicine are included in the bibliography.1-2
Table 4 is a suggested modus operandi for ordering screening pulmonary function studies for specific
problems. Physicians ordering such tests must realize
that measurements of lung mechanics require both
cooperation apd effort. Too much testing at a sing!~
sitting may fatigue the patient and cause spuriously

abnormal results. For example, it would be unwise to
subject a patient to both screening studies and exercise physiology studies for suspected vascular disease
on the same day . Therefore, in the context of the
suggestions in Table 4, clinical wisdom and common
sense should dictate which tests are appropriate for
individual patients. .
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